See All Slides - tctmd.com

Slides

$Mobilized CD 34+ Cells for Refractory Angina$

Presentation TCT 2012

Mobilized CD 34+ Cells for Refractory Angina

Presenter: Thomas Povsic

October 22, 2012

Presentation TCT 2012

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

Presenter: Anupam Bhambhani

October 22, 2012

Presentation TCT 2012

The Roadmap to Successful Funding and Support for Studies in Latin America

Presenter: Alejandra Guerchicoff

October 22, 2012

Presentation TCT 2012

TAVR Use Patterns on the European Continent: Growth, Penetration, and Reimbursement

Presenter: Nicolo Piazza

October 22, 2012

Presentation TCT 2012

Mitral Valve Disease Hemodynamics, Balloon Valvuloplasty and the Edge-to-Edge Approach (Including Related Guidelines)

Presenter: Zoltan Turi

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

Ixmyelocel-T for CHF: Results of Catheter-based Study

Presenter: Timothy Henry

October 22, 2012

Presentation TCT 2012

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES?

Presenter: Dean Kereiakes

October 22, 2012

Presentation TCT 2012

Screening and Enrollment(2)

Presenter: George Dangas

October 22, 2012

Advertisement

Slides

Mobilized CD 34+ Cells for Refractory Angina

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

The Roadmap to Successful Funding and Support for Studies in Latin America

TAVR Use Patterns on the European Continent: Growth, Penetration, and Reimbursement

Mitral Valve Disease Hemodynamics, Balloon Valvuloplasty and the Edge-to-Edge Approach (Including Related Guidelines)

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Ixmyelocel-T for CHF: Results of Catheter-based Study

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES?

Screening and Enrollment(2)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content